Business

February 3, 2014

Cornerstone shareholders approve Chiesi merger

Cornerstone Therapeutics stockholders approved the Cary drug developer’s merger with Italy’s Chiesi Farmaceutici on Monday.

Related content

Comments

Videos

Editor's Choice Videos